Compounding pharmacies (503A/503B) are regulated US facilities that create custom drug formulations. They've been a popular source for GLP-1 medications, often adding B12 or other vitamins to differentiate their product from brand-name versions. Gray market refers to research peptides sold directly by manufacturers/finishers, primarily based in China, outside the pharmaceutical regulatory framework.